Skip to main content

Amgen Inc

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Amgen Inc as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

NMRA Neumora Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 19, 2023 (view filing)Sep 19Same dayAmgen Inc10% OwnerPPurchase+1.76M$17.00+$30.0M+5.3%35.4M after

ONC BeOne Medicines Ltd.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 13, 2021 (view filing)Sep 103 daysAmgen Inc10% OwnerPPurchaseAmerican Depositary Shares+165.5K$302.06+$50.0M+0.9%18.9M after